Fluid markers of synapse degeneration in synucleinopathies.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Works matching IS 03009564 AND DT 2022 AND VI 129 AND IP 2
Results: 9
1
2
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles.
- Published in:
- Journal of Neural Transmission, 2022, v. 129, n. 2, p. 231, doi. 10.1007/s00702-022-02474-9
- By:
- Publication type:
- Article
3
Tau proteins in blood as biomarkers of Alzheimer's disease and other proteinopathies.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
4
Correction to: Proteinopathies: molecular mechanisms and diagnostic perspectives.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
5
Proteinopathies: molecular mechanisms and diagnostic perspectives.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
6
Proteinopathies associated to repeat expansion disorders.
- Published in:
- Journal of Neural Transmission, 2022, v. 129, n. 2, p. 173, doi. 10.1007/s00702-021-02454-5
- By:
- Publication type:
- Article
7
Comparison of cerebrospinal fluid tau, ptau(181), synuclein, and 14-3-3 for the detection of Creutzfeldt–Jakob disease in clinical practice.
- Published in:
- Journal of Neural Transmission, 2022, v. 129, n. 2, p. 133, doi. 10.1007/s00702-021-02443-8
- By:
- Publication type:
- Article
8
Protein clearance strategies for disease intervention.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
9
Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review